Title : Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma.

Pub. Date : 2019

PMID : 31011424






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Inotuzumab ozogamicin (INO), a CD22 antibody conjugated with calicheamicin is one of the newest ADCs. OZOGAMICIN CD22 molecule Homo sapiens